Olivier P Joffre

6PUBLICATIONS
48CO-AUTHORS
Molecular targetsInnate immunityTissue engineeringApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 20, 2025
Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer.

Alice Talpin, Ana Maia, Jean-Marie Carpier

|Jan 10, 2025
Heterochromatic gene silencing controls CD4+ T cell susceptibility to regulatory T cell-mediated suppression in a murine allograft model.

Julie Noguerol, Karl Laviolette, Margot Zahm

|Dec 05, 2024
Fine-tuning levels of filamins a and b as a specific mechanism sustaining Th2 lymphocyte functions.

Kilian Maire, Léa Chamy, Samira Ghazali

|Jul 31, 2020
Robust intrathymic development of regulatory T cells in young NOD mice is rapidly restrained by recirculating cells.

Julie Darrigues, Jeremy C Santamaria, Ariel Galindo-Albarrán

|Apr 02, 2020
[Endogenous retroviruses: friend or foe of the immune system?]

Véronique Adoue, Olivier Joffre

|Nov 29, 2019
Critical role for TRIM28 and HP1β/γ in the epigenetic control of T cell metabolic reprograming and effector differentiation.

Ulf Gehrmann, Marianne Burbage, Elina Zueva

Pageof 1

Frequent Collaborators

2 joint publications

Florence Cammas

2 joint publications

Margot Zahm

2 joint publications

Adeline Chaubet

2 joint publications

Joost Pm van Meerwijk